David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.15% |
| 2 | Financials | 9.51% |
| 3 | Healthcare | 7.52% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Perella Weinberg Partners
PWP
$1.23B
| $296K | ﹤0.01% |
46,754
-84,295
| -64% | -$598K |
|
|
TPC
4152
Tutor Perini Cor
TPC
$4.59B
| $296K | ﹤0.01% |
53,567
-26,154
| -33% | -$198K |
|
|
NGD
4153
DELISTED
New Gold Inc
NGD
| $295K | ﹤0.01% |
335,054
+226,710
| +209% | +$179K |
|
4154
Evertec
EVTC
$1.79B
| $294K | ﹤0.01% |
+9,392
| New | +$330K |
|
4155
1st Source
SRCE
$2.07B
| $294K | ﹤0.01% |
6,350
-662
| -9% | -$31.4K |
|
|
NATI
4156
DELISTED
National Instruments Corp
NATI
| $294K | ﹤0.01% |
7,795
-108,779
| -93% | -$4.11M |
|
4157
ATN International
ATNI
$473M
| $293K | ﹤0.01% |
7,590
-100
| -1% | -$4.53K |
|
4158
Midland States Bancorp
MSBI
$679M
| $293K | ﹤0.01% |
12,436
-16,258
| -57% | -$420K |
|
4159
CALL
Parker-Hannifin
PH
$128B
| $291K | ﹤0.01% |
1,200
-2,400
| -67% | -$650K |
|
|
HTLF
4160
DELISTED
Heartland Financial USA, Inc.
HTLF
| $291K | ﹤0.01% |
6,704
-3,712
| -36% | -$165K |
|
|
BCPC
4161
Balchem Corp
BCPC
$5.72B
| $290K | ﹤0.01% |
2,386
-14,815
| -86% | -$1.93M |
|
4162
1stdibs.com
DIBS
$151M
| $289K | ﹤0.01% |
45,900
-33,912
| -42% | -$220K |
|
|
HLLY.WS
4163
DELISTED
Holley Inc Warrants
HLLY.WS
| $289K | ﹤0.01% |
447,390
+279,827
| +167% | +$441K |
|
4164
Liquidity Services
LQDT
$1.35B
| $287K | ﹤0.01% |
17,665
-51,123
| -74% | -$899K |
|
4165
Buckle
BKE
$2.25B
| $286K | ﹤0.01% |
9,039
-46,045
| -84% | -$1.45M |
|
4166
Vir Biotechnology
VIR
$1.81B
| $286K | ﹤0.01% |
14,818
+6,230
| +73% | +$158K |
|
4167
Arvinas
ARVN
$628M
| $284K | ﹤0.01% |
6,377
-7,060
| -53% | -$343K |
|
4168
Simulations Plus
SLP
$372M
| $282K | ﹤0.01% |
+5,800
| New | +$339K |
|
4169
Washington Trust Bancorp
WASH
$755M
| $282K | ﹤0.01% |
+6,059
| New | +$310K |
|
4170
CALL
Carnival Corporation Ltd
CCL
$35.8B
| $281K | ﹤0.01% |
40,000
| – | – |
|
4171
Immersion
IMMR
$254M
| $281K | ﹤0.01% |
51,040
+31,313
| +159% | +$177K |
|
4172
CALL
NovoCure
NVCR
$2.05B
| $281K | ﹤0.01% |
+3,700
| New | +$289K |
|
4173
Actinium Pharmaceuticals
ATNM
$33.9M
| $280K | ﹤0.01% |
37,924
+20,600
| +119% | +$128K |
|
4174
Great Southern Bancorp
GSBC
$857M
| $280K | ﹤0.01% |
4,902
-586
| -11% | -$35.4K |
|
|
TCRR
4175
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $280K | ﹤0.01% |
155,495
-423,392
| -73% | -$1.23M |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.